Identify Compounds' Target Against Alzheimer's Disease Based on In-Silico Approach.

BACKGROUND Alzheimer's disease swept every corner of the globe and the number of patients worldwide has been rising. At present, there are as many as 30 million people with Alzheimer's disease in the world, and it is expected to exceed 80 million people by 2050. Consequently, the study of Alzheimer's drugs has become one of the most popular medical topics. METHODS In this study, in order to build a predicting model for Alzheimer's drugs and targets, the attribute discriminators CfsSubsetEval, ConsistencySubsetEval and FilteredSubsetEval are combined with search methods such as BestFirst, GeneticSearch and Greedystepwise to filter the molecular descriptors. Then the machine learning algorithms such as BayesNet, SVM, KNN and C4.5 are used to construct the 2D-Structure Activity Relationship(2D-SAR) model. Its modeling results are utilized for Receiver Operating Characteristic curve(ROC) analysis. RESULTS The prediction rates of correctness using Randomforest for AChE, BChE, MAO-B, BACE1, Tau protein and Non-inhibitor are 77.0%, 79.1%, 100.0%, 94.2%, 93.2% and 94.9%, respectively, which are overwhelming as compared to those of BayesNet, BP, SVM, KNN, AdaBoost and C4.5. CONCLUSION In this paper, we conclude that Random Forest is the best learner model for the prediction of Alzheimer's drugs and targets. Besides, we set up an online server to predict whether a small molecule is the inhibitor of Alzheimer's target at http://47.106.158.30:8080/AD/. Furthermore, it can distinguish the target protein of a small molecule.

[1]  Inder M Verma,et al.  Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Takeshi Iwatsubo,et al.  Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins* , 2005, Journal of Biological Chemistry.

[3]  Vladimir Vapnik,et al.  An overview of statistical learning theory , 1999, IEEE Trans. Neural Networks.

[4]  Yong Zhou,et al.  A Computational-Based Method for Predicting Drug-Target Interactions by Using Stacked Autoencoder Deep Neural Network , 2017, J. Comput. Biol..

[5]  John Q Trojanowski,et al.  High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. , 2007, Biochemical and biophysical research communications.

[6]  Xiao-Ping Shi,et al.  Biochemical and cell-based assays for characterization of BACE-1 inhibitors. , 2005, Analytical biochemistry.

[7]  Qi Zhang,et al.  Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor. , 2008, Bioorganic & medicinal chemistry letters.

[8]  Angelo Carotti,et al.  In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors. , 2015, European journal of medicinal chemistry.

[9]  Xiaorui Cheng,et al.  Design and synthesis of 5-cyclopropyl substituted cyclic acylguanidine compounds as BACE1 inhibitors , 2016 .

[10]  Zha-Jun Zhan,et al.  Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities. , 2010, Bioorganic & medicinal chemistry letters.

[11]  Laura Pérez-Benito,et al.  Application of Free Energy Perturbation for the Design of BACE1 Inhibitors , 2016, J. Chem. Inf. Model..

[12]  Jee Hyun Choi,et al.  Social Event Memory Test (SEMT): A Video-based Memory Test for Predicting Amyloid Positivity for Alzheimer’s Disease , 2018, Scientific Reports.

[13]  Silvia Gobbi,et al.  Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238. , 2010, Bioorganic & medicinal chemistry.

[14]  M. Katharine Holloway,et al.  BACE-1 inhibition by a series of ψ[CH2NH] reduced amide isosteres , 2006 .

[15]  Philippe Robert,et al.  PRAXIS: Towards automatic cognitive assessment using gesture recognition , 2018, Expert Syst. Appl..

[16]  Sankalp Jain,et al.  Comparing the performance of meta-classifiers—a case study on selected imbalanced data sets relevant for prediction of liver toxicity , 2018, Journal of Computer-Aided Molecular Design.

[17]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[18]  Li Wang,et al.  Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease. , 2014, European journal of medicinal chemistry.

[19]  Mohammad Hossein Fazel Zarandi,et al.  Hybrid intelligent approach for diagnosis of the lung nodule from CT images using spatial kernelized fuzzy c-means and ensemble learning , 2018, Math. Comput. Simul..

[20]  Juan Manuel Maler,et al.  Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer’s disease , 2007, Journal of Molecular Neuroscience.

[21]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[22]  Dazhe Zhao,et al.  ℓ2, 1-ℓ1 regularized nonlinear multi-task representation learning based cognitive performance prediction of Alzheimer's disease , 2018, Pattern Recognit..

[23]  Ruili Huang,et al.  Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. , 2009, Biochemistry.

[24]  E. Mandelkow,et al.  Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. , 2007, Angewandte Chemie.

[25]  Christian Igel,et al.  Deep Feature Learning for Knee Cartilage Segmentation Using a Triplanar Convolutional Neural Network , 2013, MICCAI.

[26]  Ayse Ercan,et al.  Pyrazoline-based mycobactin analogues as MAO-inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[27]  Ron Kohavi,et al.  Wrappers for Feature Subset Selection , 1997, Artif. Intell..

[28]  J Obenberger,et al.  [Selegiline in the treatment of Alzheimer's disease]. , 1995, Casopis lekaru ceskych.

[29]  Peng-Bo Zhang,et al.  A Novel AdaBoost Framework With Robust Threshold and Structural Optimization , 2018, IEEE Transactions on Cybernetics.

[30]  Wei Zhang,et al.  Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors. , 2015, Bioorganic & medicinal chemistry.

[31]  Bing Niu,et al.  Application of Machine Learning Approaches for Protein-protein Interactions Prediction. , 2017, Medicinal chemistry (Shariqah (United Arab Emirates)).

[32]  Jason Weston,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.

[33]  A. Cavalli,et al.  Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds. , 2008, Bioorganic & medicinal chemistry letters.

[34]  N. Altman.  An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression , 1992 .

[35]  K. Bae,et al.  β-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma , 2007 .

[36]  Hai-mei Hu,et al.  Multi-armed poly(L-glutamic acid)-graft-polypropyleneinime as effective and serum resistant gene delivery vectors. , 2014, International journal of pharmaceutics.

[37]  Kadir Ozden Yerdelen,et al.  Synthesis, docking and biological evaluation of oxamide and fumaramide analogs as potential AChE and BuChE inhibitors , 2014, Medicinal Chemistry Research.

[38]  Pran Kishore Deb,et al.  Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors , 2012, Molecular Diversity.

[39]  Jean-Louis Kraus,et al.  BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline. , 2006, Bioorganic & medicinal chemistry letters.

[40]  Boris Schmidt,et al.  Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. , 2007, Biochemistry.

[41]  A-Xing Zhu,et al.  Landslide susceptibility modelling using GIS-based machine learning techniques for Chongren County, Jiangxi Province, China. , 2018, The Science of the total environment.

[42]  David W McClymont,et al.  Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush. , 2008, Journal of medicinal chemistry.

[43]  Qin Chen,et al.  2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors , 2017, Molecular Diversity.

[44]  M. Roth,et al.  Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Hilkka Soininen,et al.  Synergistic effect of apolipoprotein E ϵ4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease , 2008, Pharmacogenetics and genomics.

[46]  Paweł Szymański,et al.  Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors. , 2013, European journal of medicinal chemistry.